Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse

Florian Babor, Angela R. Manser, Johannes C. Fischer, Nadine Scherenschlich, Jürgen Enczmann, Olympe Chazara, Ashley Moffett, Arndt Borkhardt, Roland Meisel, Markus Uhrberg

Blood (2014) 124 (14): 2248–2251.

https://doi.org/10.1182/blood-2014-05-572065

Published: 2014

Includes: Supplemental data

Journal Articles

Multiple myeloma–related deregulation of bone marrow–derived CD34 + hematopoietic stem and progenitor cells

Blood (2012) 120 (13): 2620–2630.

https://doi.org/10.1182/blood-2011-04-347484

Published: 2012

Includes: Supplemental data

Journal Articles

Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I

Kathrin Schönberg, Johannes C. Fischer, Gesine Kögler, Markus Uhrberg

Blood (2011) 117 (19): 5152–5156.

https://doi.org/10.1182/blood-2011-02-334441

Published: 2011

Journal Articles

Analyses of HLA-C–specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition

Kathrin Schönberg, Martina Sribar, Jürgen Enczmann, Johannes C. Fischer, Markus Uhrberg

Blood (2011) 117 (1): 98–107.

https://doi.org/10.1182/blood-2010-03-273656

Published: 2011

Includes: Supplemental data

Journal Articles

Malignant Myeloma Cells Impair Phenotype and Function of stem and Progenitor Cells.

Ingmar Bruns, MD, PhD, Sebastian Büst, Akos G. Czibere, MD, Ron-Patrick Cadeddu, Ines Brückmann, Manoj Bhasin, Johannes C Fischer, Roland Fenk, Guido Kobbe, MD, Andreas Trumpp, Rainer Haas

Blood (2009) 114 (22): 1799.

https://doi.org/10.1182/blood.V114.22.1799.1799

Published: 2009

Journal Articles

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

Ron-Patrick Cadeddu, Akos G. Czibere, MD, Sebastian Büst, Johannes C Fischer, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Guido Kobbe, MD, Rainer Haas, Ingmar Bruns, MD, PhD

Blood (2009) 114 (22): 4593.

https://doi.org/10.1182/blood.V114.22.4593.4593

Published: 2009

Journal Articles

Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.

Ingmar Bruns, MD, PhD, Akos Czibere, MD, PhD, Patrick Cadeddu, Frederik Roels, Johannes C Fischer, Sebastian Büst, Daniela Brünnert, Ulrich Steidl, MD, PhD, Benedict Brors, Norbert Gattermann, MD, Ralf Kronenwett, Rainer Haas

Blood (2008) 112 (11): 3365.

https://doi.org/10.1182/blood.V112.11.3365.3365

Published: 2008

Journal Articles

The Neuropeptides Orexin a and B Have An Impact on Functional Properties of Human CD34+ Stem and Progenitor Cells.

Ingmar Bruns, MD, PhD, Patrick Cadeddu, Sebastian Büst, Boris Goerg, Johannes C Fischer, Oliver Selbach, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Rainer Haas, Guido Kobbe, Akos Czibere, MD, PhD

Blood (2008) 112 (11): 1393.

https://doi.org/10.1182/blood.V112.11.1393.1393

Published: 2008

Journal Articles

Relevance of HLA-C Epitopes C1 and C2 for the Survival of Patients with AML and CML after Allogeneic Blood Stem Cell Transplantation.

Ingmar Bruns, MD, Akos G. Czibere, MD, Markus Uhrberg, Jürgen Enczmann, MD, Guido Kobbe, MD, Frank Neumann, MD, Peter Wernet, MD, Rainer Haas, MD, Johannes C. Fischer, MD

Blood (2007) 110 (11): 1974.

https://doi.org/10.1182/blood.V110.11.1974.1974

Published: 2007

Journal Articles

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Ingmar Bruns, MD, Johannes C. Fischer, MD, Akos G. Czibere, MD, Cangül Kilic, Roland Fenk, MD, Fabian Zohren, MD, Ralf Kronenwett, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2007) 110 (11): 4920.

https://doi.org/10.1182/blood.V110.11.4920.4920

Published: 2007

Journal Articles

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Ingmar Bruns, MD, Akos G. Czibere, MD, Johannes C. Fischer, MD, Ulrich Steidl, MD, PhD, Sabrina Pechtel, Annemarie Koch, Daniela Brünnert, Sebastian Büst, Ron-Patrick Cadeddu, Ralf Kronenwett, MD, Rainer Haas, MD

Blood (2007) 110 (11): 3170.

https://doi.org/10.1182/blood.V110.11.3170.3170

Published: 2007

Journal Articles

Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins

Julia Beckmann, Sebastian Scheitza, Peter Wernet, Johannes C. Fischer, Bernd Giebel

Blood (2007) 109 (12): 5494–5501.

https://doi.org/10.1182/blood-2006-11-055921

Published: 2007

Includes: Supplemental data

Journal Articles

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Johannes C. Fischer, MD, Sascha Raschke, Guido Kobbe, PhD, Roland Fenk, MD, Michael Rosskopf, Sabrina Pechtel, Ulrich-Peter Rohr, PhD, Arndt von Haeseler, PhD, Peter Wernet, PhD, Daniel Tenen, PhD, Rainer Haas, PhD, Ralf Kronenwett, PhD

Blood (2006) 108 (11): 3382.

https://doi.org/10.1182/blood.V108.11.3382.3382

Published: 2006

NARROW

KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse

Multiple myeloma–related deregulation of bone marrow–derived CD34 + hematopoietic stem and progenitor cells

Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I

Analyses of HLA-C–specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition

Malignant Myeloma Cells Impair Phenotype and Function of stem and Progenitor Cells.

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.

The Neuropeptides Orexin a and B Have An Impact on Functional Properties of Human CD34+ Stem and Progenitor Cells.

Relevance of HLA-C Epitopes C1 and C2 for the Survival of Patients with AML and CML after Allogeneic Blood Stem Cell Transplantation.

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only